Immune Response to a Recombinant Hepatitis B Vaccine in Hemodialysis Patients

1990 ◽  
Vol 13 (7) ◽  
pp. 451-453 ◽  
Author(s):  
D. Docci ◽  
P.A. Cipolloni ◽  
L. Baldrati ◽  
C. Capponcini ◽  
F. Turci ◽  
...  
Nephron ◽  
1996 ◽  
Vol 72 (4) ◽  
pp. 536-543 ◽  
Author(s):  
F. Fabrizi ◽  
S. Di Filippo ◽  
D. Marcelli ◽  
I. Guarnori ◽  
L. Raffaele ◽  
...  

Author(s):  
C. F. T. Yoshida ◽  
C. Takahashi ◽  
L. A. C. Mercadante ◽  
I. F. Camargo ◽  
H. G. Schatzmayr

Immune response against hepatitis B vaccine (CLB 3mg) was evaluated in 59 hemodialysis patients and 20 occupational risk personnel. Seroconversion was induced in 52.5% and 70.0% respectively. Twelve months after the first dose, 37.5% of patients and 60.0% of occupational risk personnel had detectable anti-HBs level. Antibody level was expressed in sample ratio units (SRU). Considering only the responders, in the patients group 38.7% had a low anti-HBs response (2.1-9.9 SRU) 32.3% a medium response (10-99.9 SRU) and 29.0% a high response (>100 SRU) while in occupational risk personnel these values were 14.3%, 64.3% and 21.4% respectively. The authors suggest the use of HBV vaccines with more elevated HBsAg concentration or a reinforced immunization schedule to improve the anti-HBs response not only for patients but also for healthy persons.


1996 ◽  
Vol 13 (5) ◽  
pp. 425-431 ◽  
Author(s):  
Sophia Polychronopoulou-Androulakaki ◽  
John P. Panagiotou ◽  
Stavroula Kostaridou ◽  
Asimina Kyratzopoulou ◽  
Stavros Haidas

PEDIATRICS ◽  
2008 ◽  
Vol 121 (6) ◽  
pp. e1570-e1576 ◽  
Author(s):  
E. Nemes ◽  
E. Lefler ◽  
L. Szegedi ◽  
A. Kapitany ◽  
J. B. Kovacs ◽  
...  

1992 ◽  
Vol 12 (6) ◽  
pp. 477-477 ◽  
Author(s):  
Dino Docci ◽  
Leopoldo Baldrati ◽  
Claudio Capponcini ◽  
Carlo Feletti

Sign in / Sign up

Export Citation Format

Share Document